These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30642934)

  • 1. Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.
    Tomich AD; Klontz EH; Deredge D; Barnard JP; McElheny CL; Eshbach ML; Weisz OA; Wintrode P; Doi Y; Sundberg EJ; Sluis-Cremer N
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coli.
    Klontz EH; Tomich AD; Günther S; Lemkul JA; Deredge D; Silverstein Z; Shaw JF; McElheny C; Doi Y; Wintrode PL; MacKerell AD; Sluis-Cremer N; Sundberg EJ
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal
    Ito R; Mustapha MM; Tomich AD; Callaghan JD; McElheny CL; Mettus RT; Shanks RMQ; Sluis-Cremer N; Doi Y
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular model to study FosA enzyme inhibition.
    Josino LPC; Alves CN; Lima AH
    J Mol Graph Model; 2021 Sep; 107():107978. PubMed ID: 34217024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.
    Guo Q; Tomich AD; McElheny CL; Cooper VS; Stoesser N; Wang M; Sluis-Cremer N; Doi Y
    J Antimicrob Chemother; 2016 Sep; 71(9):2460-5. PubMed ID: 27261267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France.
    Benzerara Y; Gallah S; Hommeril B; Genel N; Decré D; Rottman M; Arlet G
    Emerg Infect Dis; 2017 Sep; 23(9):1564-1567. PubMed ID: 28820368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The revival of fosfomycin.
    Michalopoulos AS; Livaditis IG; Gougoutas V
    Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial activity of fosfomycin under various conditions against standard strains, beta-lactam resistant strains, and multidrug efflux system mutants].
    Mikuniya T; Hiraishi T; Maebashi K; Ida T; Takata T; Hikida M; Yamada S; Gotoh N; Nishino T
    Jpn J Antibiot; 2005 Apr; 58(2):105-22. PubMed ID: 15997654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy.
    Sime FB; Johnson A; Whalley S; Santoyo-Castelazo A; Montgomery AB; Walters KA; Lipman J; Hope WW; Roberts JA
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli.
    Ma Y; Xu X; Guo Q; Wang P; Wang W; Wang M
    Lett Appl Microbiol; 2015 Mar; 60(3):259-64. PubMed ID: 25441705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.
    Chen J; Wang D; Ding Y; Zhang L; Li X
    Microb Drug Resist; 2019 Mar; 25(2):251-257. PubMed ID: 30113251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to polymyxins in Gram-negative organisms.
    Jeannot K; Bolard A; Plésiat P
    Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of fosfomycin resistance and plasmid-mediated fosfomycin-modifying enzymes among carbapenem-resistant Enterobacteriaceae in Zhejiang, China.
    Huang L; Hu YY; Zhang R
    J Med Microbiol; 2017 Sep; 66(9):1332-1334. PubMed ID: 28885139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
    Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
    Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.